ITC To Review Drugs Up For Duty-Free Treatment

Law360, New York (June 10, 2010, 1:47 PM EDT) -- The U.S. International Trade Commission has launched a new investigation to examine more than 700 pharmaceutical products and chemical intermediates that the Obama administration is proposing to make duty-free.

The ITC said Wednesday that it opened the review after the Office of the U.S. Trade Representative asked the agency last month to provide advice on the drugs proposed to be added to the Pharmaceutical Appendix to the Harmonized Tariff Schedule of the United States, which would allow the drugs to receive duty-free treatment.

The HTS, which...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.